Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma (Q38954672)

7 September 2017

Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma (English)

1 reference

7 September 2017

neoplastic stem cells

1 reference

Dan Yu

1

1 reference

7 September 2017

Yan Liu

2

1 reference

7 September 2017

Jingpu Yang

3

1 reference

7 September 2017

Chunshun Jin

4

1 reference

7 September 2017

Xue Zhao

5

1 reference

7 September 2017

Jinzhang Cheng

6

1 reference

7 September 2017

Xueshibojie Liu

7

1 reference

7 September 2017

Xinmeng Qi

8

1 reference

7 September 2017

1 January 2015

1 reference

Cell Biochemistry and Biophysics

7 September 2017

1 reference

7 September 2017

71

1 reference

7 September 2017

1

1 reference

7 September 2017

261-269

1 reference

https://scigraph.springernature.com/pub.10.1007/s12013-014-0194-z

7 September 2017

0 references

cites work

Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Resistance to chemotherapy: new treatments and novel insights into an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Stem cells and cancer: an intimate relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Cancer stem cells and their potential implications for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification of bronchioalveolar stem cells in normal lung and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification of local and circulating cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Cancer stem cells: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

CD133 expression predicts for non-response to chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

CD133, one of the markers of cancer stem cells in Hep-2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Polycomb silencers control cell fate, development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0194-Z

10.1007/S12013-014-0194-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference